EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $15.68 and traded as high as $18.00. EUDA Health shares last traded at $17.70, with a volume of 35,612 shares traded.
Analysts Set New Price Targets
A number of research analysts have recently commented on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. Wall Street Zen raised shares of EUDA Health to a “hold” rating in a report on Saturday, October 17th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, EUDA Health presently has an average rating of “Hold” and an average price target of $55.00.
EUDA Health Price Performance
The company has a 50 day moving average price of $15.56 and a 200-day moving average price of $15.68. The company has a quick ratio of 2.53, a current ratio of 2.53 and a debt-to-equity ratio of 0.01.
EUDA Health (NASDAQ:EUDA – Get Free Report) last issued its quarterly earnings data on Tuesday, September 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The company had revenue of $1.73 million for the quarter, compared to analyst estimates of $9.61 million.
EUDA Health Company Profile
EUDA Health Limited (NASDAQ: EUDA) is a digital health company focused on improving access to healthcare through technology-enabled services. The company’s activities center on virtual care and healthcare platforms designed to connect patients with providers and support the delivery of convenient, digitally enabled medical services.
EUDA Health’s offerings include telehealth and other digital healthcare solutions, with an emphasis on behavioral and mental health services. Its platforms are intended to help patients access care remotely while supporting healthcare professionals with tools for communicating with and managing patients.
The company serves users primarily through digital channels and has focused its commercial activities on the U.S.
Recommended Stories
- Five stocks we like better than EUDA Health
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
